OOIR: Observatory of International Research

Papers

(The H4-Index of Reviews in Endocrine & Metabolic Disorders is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Looking beyond fat in obesity: the frequently overlooked importance of muscle mass	143
Pegvisomant in managing comorbidities of acromegaly: a review	122
Traumatic brain injury and prolactin	119
Effectiveness and safety of continuous subcutaneous hydrocortisone infusion in managing adrenocortical insufficiency in adult patients: a systematic review	109
Insulin icodec: A novel once-weekly formulation for the treatment of type 1 and type 2 diabetes mellitus	108
Epigenetic programming for obesity and noncommunicable disease: From womb to tomb	103
Predictors of incident diabetic peripheral neuropathy: a systematic review of longitudinal studies in patients with diabetes mellitus	81
Application of radiomics and machine learning to thyroid diseases in nuclear medicine: a systematic review	66
Association between continuous glucose monitoring metrics and cardiovascular autonomic neuropathy in diabetic patients: a systematic review	66
Patient and health care provider knowledge of diabetes and diabetic microvascular complications: a comprehensive literature review	64
Pathophysiological insights into asprosin: an emerging adipokine in reproductive health	64
Diagnostic and prognostic utility of phase angle in patients with cancer	63
The genetics of Graves’ disease	60
Replacement with sex steroids in hypopituitary men and women: implications for gender differences in morbidities and mortality	57
New drugs for the treatment of obesity: do we need approaches to preserve muscle mass?	56
Endocrine responses of the stress system to different types of exercise	52
Revisiting the endocrine and metabolic manifestations of COVID-19 two years into the pandemic	51
Preface	50
Use of thermal imaging in the detection of the diabetic foot- review	50
Central and peripheral regulation of the GH/IGF-1 axis: GHRH and beyond	48
A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease	48
Androgens, aging, and prostate health	47
Emerging role of AgRP neurons as integrators of metabolic, sensory and environmental cues in the control of energy homeostasis	47
Prolactin deficiency in the context of other pituitary hormone abnormalities	45
Posttranslational modifications in diabetes: Mechanisms and functions	43

Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable disease	43
Mention to Prof. Andrew V. Schally	41
Preoperative systemic inflammatory markers as prognostic factors in differentiated thyroid cancer: a systematic review and meta-analysis	41
Neurovascular plasticity as a modulator of hypothalamic function	41
No longer to be ignored: Hypophosphatemia following intravenous iron administration	40
Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries	40
Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review	40
The hypothalamus as a therapeutic target: Towards novel approaches for managing antipsychotic-induced weight gain	38
Deep neural network for food image classification and nutrient identification: A systematic review	37
Hypothalamic GHRH	37
The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy	37
A multifaceted and inclusive methodology for the detection of sarcopenia in patients undergoing bariatric surgery: an in-depth analysis of current evidence	37